tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Almirall’s Phase 3 Study on Tirbanibulin for Actinic Keratosis: Key Insights for Investors
PremiumCompany AnnouncementsAlmirall’s Phase 3 Study on Tirbanibulin for Actinic Keratosis: Key Insights for Investors
6M ago
Almirall’s Tildrakizumab Study: Exploring Patient Wellbeing in Real-World Settings
Premium
Company Announcements
Almirall’s Tildrakizumab Study: Exploring Patient Wellbeing in Real-World Settings
7M ago
Almirall’s Study on Tildrakizumab: A Potential Game-Changer in Psoriasis Treatment?
Premium
Company Announcements
Almirall’s Study on Tildrakizumab: A Potential Game-Changer in Psoriasis Treatment?
7M ago
Almirall Strengthens Leadership and Announces Capital Increase
PremiumCompany AnnouncementsAlmirall Strengthens Leadership and Announces Capital Increase
8M ago
Is 0O9B a Buy, Before Earnings?
Premium
Pre-Earnings
Is 0O9B a Buy, Before Earnings?
8M ago
Almirall Announces Agenda for 2025 Shareholders’ Meeting
Premium
Company Announcements
Almirall Announces Agenda for 2025 Shareholders’ Meeting
10M ago
Almirall’s 2024 Success and New Remuneration Policy
PremiumCompany AnnouncementsAlmirall’s 2024 Success and New Remuneration Policy
11M ago
Almirall SA (0O9B) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Almirall SA (0O9B) Q4 Earnings Cheat Sheet
11M ago
Almirall Streamlines Portfolio with New Divestment and Licensing Agreements
Premium
Company Announcements
Almirall Streamlines Portfolio with New Divestment and Licensing Agreements
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100